Biomarin Pharmaceutical Inc (LTS:0HNC)
$ 76.46 -0.06 (-0.08%) Market Cap: 14.69 Bil Enterprise Value: 14.74 Bil PE Ratio: 72.28 PB Ratio: 2.89 GF Score: 71/100

Biomarin Pharmaceutical Inc at Bank of America NAPA Healthcare Conference (Virtual) Transcript

Jun 16, 2021 / 07:30PM GMT
Release Date Price: $82.49 (+0.26%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Okay. Welcome to the afternoon sessions of the third day of the BofA Virtual Napa Conference. I'm Geoff Meacham, I'm the senior biopharma analyst. And I have Aspen Mori from my team with me as well. And we're thrilled to have BioMarin with us. Obviously, we'd all rather be in Napa actually, but not virtually, but it is what it is.

And speaking on behalf of BioMarin, we have Chairman and CEO, J.J. Bienaimé; and we also have Brian Mueller, EVP and CFO. Hey, guys. How's it going?

Jean;Jacques Bienaime
BioMarin Pharmaceutical Inc. - Chairman & CEO

Pretty good. Thank you.

Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Yes, we've done a lot of these of late.

Jean;Jacques Bienaime;Geoffrey Christopher Meacham
BioMarin Pharmaceutical Inc. - Chairman & CEO;BofA

(inaudible)

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot